Literature DB >> 7856109

Restriction of vaccinia virus replication in CHO cells occurs at the stage of viral intermediate protein synthesis.

A Ramsey-Ewing1, B Moss.   

Abstract

Vaccina virus (VV) and cowpox virus (CPV) differ in their abilities to replicate in Chinese hamster ovary (CHO) cells because VV has a disrupted host range (hr) gene. To facilitate an examination of the molecular events associated with abortive infection of CHO cells with VV, we constructed two sets of recombinant viruses that contain a viral early promoter regulating the cat gene encoding chloramphenicol acetyltransferase and viral intermediate or late promoters regulating the lacZ gene encoding beta-galactosidase. The first set has the disrupted hr gene and the second set has the intact CPV homolog, allowing replication in CHO cells. Reporter chloramphenicol acetyltransferase and beta-galactosidase assays demonstrated that early gene expression was unperturbed, whereas intermediate and late gene expression were severely inhibited under abortive conditions. Metabolic labeling studies confirmed the absence of viral late protein synthesis. The accumulation of viral DNA under abortive conditions was consistent with the synthesis of viral early proteins and established that inhibition of late protein synthesis was not primarily due to a replicative block. Analysis of steady state levels of viral mRNAs revealed substantial quantities of early and intermediate species but only very small amounts of late mRNAs under nonpermissive conditions. Despite the presence of viral intermediate mRNAs, the corresponding intermediate proteins, which function as late transcription factors, were not detected by immunoprecipitation of lysates from metabolically labeled infected CHO cells. Furthermore, when expression of lacZ was regulated by an intermediate promoter, no beta-galactosidase was detected even though lacZ transcripts were present. Thus, the abortive phenotype in CHO cells can be explained by a block to translation of intermediate mRNAs which prevents the synthesis of late transcription factors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7856109     DOI: 10.1006/viro.1995.1021

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

1.  Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene.

Authors:  José Luis Nájera; Carmen Elena Gómez; Elena Domingo-Gil; María Magdalena Gherardi; Mariano Esteban
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

2.  Isolation and characterization of a Chinese hamster ovary mutant cell line with altered sensitivity to vaccinia virus killing.

Authors:  C H Bair; C S Chung; I A Vasilevskaya; W Chang
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

Review 3.  Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.

Authors:  B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

4.  Host-range restriction of vaccinia virus E3L-specific deletion mutants.

Authors:  E Beattie; E B Kauffman; H Martinez; M E Perkus; B L Jacobs; E Paoletti; J Tartaglia
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

5.  Restriction of vaccinia virus replication by a ced-3 and ced-4-dependent pathway in Caenorhabditis elegans.

Authors:  Wan-Hsin Liu; Yi-Ling Lin; Jia-Pey Wang; Willisa Liou; Roger F Hou; Yi-Chun Wu; Ching-Len Liao
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-06       Impact factor: 11.205

6.  Poxvirus host range protein CP77 contains an F-box-like domain that is necessary to suppress NF-kappaB activation by tumor necrosis factor alpha but is independent of its host range function.

Authors:  Shu-Jung Chang; Jye-Chian Hsiao; Stephanie Sonnberg; Cheng-Ting Chiang; Min-Hsiang Yang; Der-Lii Tzou; Andrew A Mercer; Wen Chang
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

7.  A kinome RNAi screen identified AMPK as promoting poxvirus entry through the control of actin dynamics.

Authors:  Theresa S Moser; Russell G Jones; Craig B Thompson; Carolyn B Coyne; Sara Cherry
Journal:  PLoS Pathog       Date:  2010-06-17       Impact factor: 6.823

8.  The orthopoxvirus 68-kilodalton ankyrin-like protein is essential for DNA replication and complete gene expression of modified vaccinia virus Ankara in nonpermissive human and murine cells.

Authors:  Karin M Sperling; Astrid Schwantes; Caroline Staib; Barbara S Schnierle; Gerd Sutter
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

9.  Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.

Authors:  Simone Hornemann; Olof Harlin; Caroline Staib; Sigrid Kisling; Volker Erfle; Bernd Kaspers; Georg Häcker; Gerd Sutter
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

10.  A role for the host coatomer and KDEL receptor in early vaccinia biogenesis.

Authors:  Leiliang Zhang; Stella Y Lee; Galina V Beznoussenko; Peter J Peters; Jia-Shu Yang; Hui-ya Gilbert; Abraham L Brass; Stephen J Elledge; Stuart N Isaacs; Bernard Moss; Alexander Mironov; Victor W Hsu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.